| Line item in (gbp) | 01.01.2022 | 01.01.2023 | 01.01.2024 |
|---|---|---|---|
| Assets | N/A | 8,346,000.00 | 2,184,000.00 |
| Noncurrent Assets | N/A | 26,000.00 | 306,000.00 |
| Property Plant And Equipment | N/A | 7,000.00 | 3,000.00 |
| Other Noncurrent Assets | N/A | 19,000.00 | 19,000.00 |
| Current Assets | N/A | 8,320,000.00 | 1,878,000.00 |
| Trade And Other Current Receivables | N/A | 1,219,000.00 | 1,026,000.00 |
| Trade And Other Current Receivables Due From Related Parties | N/A | 0.00 | 847,000.00 |
| Cash and cash equivalents | N/A | 257,000.00 | 5,000.00 |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 1,476,000.00 | 1,878,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | N/A | 6,844,000.00 | 0.00 |
| Equity | -1,425,000.00 | -2,025,000.00 | -3,807,000.00 |
| Issued Capital | N/A | 5,897,000.00 | 5,989,000.00 |
| Retained Earnings | N/A | -27,649,000.00 | -32,113,000.00 |
| Share Premium | N/A | 25,269,000.00 | 25,396,000.00 |
| Other Reserves | N/A | -11,413,000.00 | -11,048,000.00 |
| Reserve Of Sharebased Payments | N/A | 5,871,000.00 | 7,969,000.00 |
| Noncurrent Liabilities | N/A | 1,223,000.00 | 1,422,000.00 |
| Noncurrent Provisions | N/A | 468,000.00 | 575,000.00 |
| Deferred Tax Liabilities | N/A | 7,000.00 | 7,000.00 |
| Longterm Borrowings | N/A | 748,000.00 | 840,000.00 |
| Current Liabilities | N/A | 9,148,000.00 | 4,569,000.00 |
| Trade And Other Current Payables | N/A | 4,587,000.00 | 4,569,000.00 |
| Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 4,561,000.00 | 0.00 |
| Line item in (gbp) | 01.01.2022/ 01.01.2023 |
01.01.2023/ 01.01.2024 |
|---|---|---|
| Revenue | 138,000.00 | 158,000.00 |
| Profit Loss From Operating Activities | -5,729,000.00 | -4,077,000.00 |
| Finance Costs | 1,982,000.00 | 83,000.00 |
| Impairment Loss Impairment Gain And Reversal Of Impairment Loss Determined In Accordance With I F R S9 | 1,078,000.00 | 384,000.00 |
| Profit Loss Before Tax | -7,711,000.00 | -4,160,000.00 |
| Income Tax Expense Continuing Operations | 0.00 | 0.00 |
| Profit Loss From Continuing Operations | -7,711,000.00 | -4,160,000.00 |
| Profit Loss From Discontinued Operations | -2,167,000.00 | -185,000.00 |
| Profit (loss) | -9,878,000.00 | -4,345,000.00 |
| Profit Loss Attributable To Owners Of Parent | -10,417,000.00 | -4,041,000.00 |
| Line item in (gbp) | 01.01.2023 | 01.01.2024 |
|---|---|---|
| Profit (loss) | -9,878,000.00 | -4,345,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 1,843,000.00 | 384,000.00 |
| Adjustments For Provisions | 110,000.00 | 118,000.00 |
| Adjustments For Fair Value Gains Losses | 0.00 | 68,000.00 |
| Other Adjustments For Noncash Items | -134,000.00 | 137,000.00 |
| Cash Flows From Used In Operations | -4,265,000.00 | -3,586,000.00 |
| Interest Paid Classified As Operating Activities | 14,000.00 | 47,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | 276,000.00 | 0.00 |
| Cash Flows From Used In Operating Activities | -4,555,000.00 | -3,633,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | 4,000.00 | 0.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | 1,175,000.00 | 458,000.00 |
| Purchase Of Other Longterm Assets Classified As Investing Activities | 18,000.00 | 0.00 |
| Cash Flows From Used In Investing Activities | -1,197,000.00 | 446,000.00 |
| Proceeds From Issuing Shares | 7,013,000.00 | 2,322,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | 2,334,000.00 | 655,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 0.00 | 105,000.00 |
| Cash Flows From Used In Financing Activities | 4,619,000.00 | 2,612,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -1,133,000.00 | -575,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -13,000.00 | -1,000.00 |
| Cash and cash equivalents | 257,000.00 | 5,000.00 |
Please note that some sums might not add up.
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.
